Showing 2351-2360 of 3138 results for "".
- Jury Still Out on Cosmetic Uses of PRPhttps://modernaesthetics.com/news/more-research-needed-on-cosmetic-uses-of-prp/2472097/Most studies evaluating platelet-rich plasma (PRP) injection for facial rejuvenation and other cosmetic procedures have reported positive results
- New ASPS Data: Minimally Invasive Aesthetic Procedures Up 200 Percent Since 2000https://modernaesthetics.com/news/new-asps-data-minimally-invasive-aesthetic-procedures-up-200-percent-since-2000/2472125/Drumroll, please… Plastic surgery is on the rise, according to the annual statistics from the American Society of Plastic
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- FDA OKs Describe Patch for Use with All Tattoo Removal Lasershttps://modernaesthetics.com/news/fda-oks-describe-patch-for-use-with-all-tattoo-removal-lasers/2472158/Merz North America’s DESCRIBE® PFD Patch is now cleared by the Food and Drug Administration (FDA) for all commonly used lasers for tattoo removal. The new FDA c
- Congrats! Lisa M. Donofrio, MD Named New ASDS/ASDSA Presidenthttps://modernaesthetics.com/news/congrats-lisa-m-donofrio-md-named-new-asdsasdsapresident/2472179/Lisa M. Donofrio, MD, is the new President of the American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA). Along with her fellow officers and the ASDS / ASDSA
- FDA Clears Fotona's StarWalker MaQX Ultra Performance Q-Switched Systemhttps://modernaesthetics.com/news/fda-clears-fotonas-starwalker-maqx-ultra-performance-q-switched-system/2472191/The FDA has cleared Fotona's StarWalker MaQX Q-Switched laser system for treating tattoos, pigmented and vascular lesions, acne and scar revision, and permanent hair reduction. The Verde 532 mode in a "tattoo laser" is exclusive to the MaQX. Sales in the US will begin immediately. T
- Allergan Upgrades Brilliant Distinctions® Patient Loyalty Programhttps://modernaesthetics.com/news/allergan-upgrades-brilliant-distinctions-patient-loyalty-program/2472200/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and dr
- Art Lesson Teaches Plastic Surgeons Better Botox Injection Techniqueshttps://modernaesthetics.com/news/art-lesson-teaches-plastic-surgeons-better-botox-injection-techniques-facebookshare-to/2472207/A highly detailed body painting project helps plastic surgeons understand how underlying muscles contribute to facial lines and wrinkles as well as how to better treat them using botulinum toxin injections. The illustrated article, which appears in Plas
- Bonti's Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://modernaesthetics.com/news/bontis-gateway-neuromodulator-performs-well-in-pase-2a-for-glabellar-lines/2472208/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serot
- Syneron Candela Becomes Private Company with Completion of Transaction with Funds Advised by Apax Partnershttps://modernaesthetics.com/news/syneron-candela-becomes-private-company-with-completion-of-transaction-with-funds-advised-by-apax-partners/2472211/Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400 million. The transacti